Back to search
FDAFDA · Food and drugs·Recall number D-0039-2024

HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC#: 68084-447-01; Individual Dose NDC: 68084-447-11

Published October 11, 2023 · Recall initiated: September 1, 2023

Summary

FDA records drug Class III recall D-0039-2024, published October 11, 2023 and initiated September 1, 2023. Recalling firm: Amerisource Health Services LLC; Status: Terminated; Reported quantity: 3,344 cartons; Lot: Lot#: 1007002, Exp 12/31/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amerisource Health Services LLC
Distributor
Nationwide in the USA
Lot
Lot#: 1007002, Exp 12/31/2023
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC#: 68084-447-01; Individual Dose NDC: 68084-447-11 recalled?

Yes. FDA published recall D-0039-2024 on October 11, 2023. Reported hazard: Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter